Regulatory considerations in application of encapsulated cell therapies

Advances in Experimental Medicine and Biology

Volumn 670, Issue , 2010, Pages 31-37

  Van Zanten, J ^a   De Vos, Paul ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ENCAPSULATION; CELL THERAPY; DOCUMENTATION; FOOD AND DRUG ADMINISTRATION; GENE THERAPY; GOOD CLINICAL PRACTICE; GOOD MANUFACTURING PRACTICE; LAW; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; TISSUE ENGINEERING; TISSUE TRANSPLANTATION; TOTAL QUALITY MANAGEMENT; CELL TRANSPLANTATION; CLINICAL TRIAL; DRUG FORMULATION; DRUG INDUSTRY; HUMAN; INSTRUMENTATION; LEGAL ASPECT; METHODOLOGY; REVIEW; UNITED STATES;

CELL TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; DRUG COMPOUNDING; DRUG INDUSTRY; GENE THERAPY; GUIDELINES AS TOPIC; HUMANS; TISSUE ENGINEERING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77951626822     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5786-3_4     Document Type: Article

References (10)

1. Visted T, Bjerkvig R, Enger PO. Cell encapsulated technology as a therapeutic strategy for CNS malignancies. Neuro-oncology 2001; 3:201-210. (Pubitemid 33674112)
2. Cirone P, Potter M, Hirte H et al. Immunoisolation in cancer gene therapy. Current Gene Therapy 2006; 6:181-191.
3. De Vos P, Faas MM, Strand B et al. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006; 27:5603-5617. (Pubitemid 44177795)
4. Caliafore R, Basta G, Luca G et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: First two cases. Diabetes Care 2006; 29:137-138. (Pubitemid 44033446)
5. Immel BK. A brief history of the GMP's: The power of storytelling. BioPharm International 2000; 61:26-36.
6. http://ec.europe.eu/enterprise/pharmaceuticals/eudralex/homev4.htm.
7. Möritz A. The new GMP environment for investigational medicinal products in the european union. BioProcess Int 2005; 3:28-38.
8. Rosin LJ. Regulatory affairs; If you didn't write it down, it didn't happen. 2006. BioProcess Int Supplement 2006; 4(3):16-23.
9. Guidance for Industry; Source Animal, product, preclinical and clinical issues regarding the use of xenotransplantation products in humans. 2003. www.fda.gov/Cber/gdlns/clinxeno.pdf.
10. Mingam I, Dupraz-Poiseau A. Current and future frameworks for cell- and tissue- based products. Bio- Process International 2006; 4(5):12-17.